Contemporary OB/GYN week in review: Endometriosis, estrogen therapy, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Endometriosis, estrogen therapy, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, June 17 - Friday, June 21, 2024), and click each link to read and watch anything you may have missed.
1.) Endometriosis linked to higher risk of mental health conditions
A study revealed that women with endometriosis are significantly more likely to develop mental health issues, including depression and anxiety.
Click here for the full article.
2.) Study finds estrogen therapy underuse after oophorectomy raises health risks
A recent highlights elevated morbidity and mortality risks in premenopausal women underusing estrogen therapy after oophorectomy, underscoring the critical need for hormone therapy to mitigate adverse health outcomes.
Click here for the full article.
3.) Maternal distress during COVID-19 linked to reduced neonatal brain volumes
A recent study found that maternal psychological distress during the COVID-19 pandemic is associated with reduced white matter and other brain volumes in newborns, highlighting potential long-term impacts on child development.
Click here for the full article.
4.) Interpregnancy interval linked to spontaneous abortion risk
A recent found that interpregnancy intervals shorter than 18 months or at least 36 months following a healthy live birth are associated with a higher risk of subsequent spontaneous abortion.
Click here for the full article.
5.) Psychological therapies found effective against childbirth-related PTSD
A recent analysis found decreased incidence and symptom frequency of childbirth-related posttraumatic stress disorder following multiple therapies, ranging from cognitive behavioral therapy to music therapy.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
